Pharmaceutical Care Research Group, University of Basel, Switzerland.
J Clin Pharm Ther. 2012 Apr;37(2):242-4. doi: 10.1111/j.1365-2710.2011.01263.x. Epub 2011 Apr 4.
Intoxication with oral low-dose methotrexate (MTX) is a well-known and frequent problem, which is often discovered accidently. The major reason is error in the frequency of dosing, mostly of daily instead of weekly intake. We report a case where the critical error was discovered by the community pharmacist during the routine implementation of the Pharmaceutical Care process SOAP while dispensing a new prescription for the patient.
A 78-year-old widow went to her regular community pharmacy to pick up a prescription for oral mucositis. The evaluation of the case by the pharmacist using the SOAP (an acronym for Subjective, Objective, Assessment and Plan) note method revealed the underlying oral low-dose MTX intoxication which led to hospitalization a few days later. The incorrect interpretation of the required dose had arisen from the written instructions for use and led to the erroneous intake of MTX daily (instead of weekly). We interviewed the patient at her home 2months after discharge. She explained that her continued intake of MTX in spite of manifest adverse effects was because of a profound conviction that she was doing right. Her confidence in physicians remained unchanged after the incident, but she would now refuse to take MTX.
The reasons for the intoxication were not discovered accidently but by the routine use of the Pharmaceutical Care process SOAP by the community pharmacist. We describe three main errors that might have been avoided and provide solutions for physicians, pharmacists, manufacturers and patients, to reduce such risks. Our case highlights the dangers of teleconsultation, the crucial role of Pharmaceutical Care provided by community pharmacists and the continued need to supply advice to patients being prescribed low-dose MTX. The fact that a patient has had a previous and successful experience with a similar treatment should not deter health professionals from verifying a patient's understanding via questions and feedback.
口服低剂量甲氨蝶呤(MTX)中毒是一个众所周知且频繁发生的问题,通常是意外发现的。主要原因是给药频率错误,大多是每日而不是每周给药。我们报告了一个案例,在为患者配药时,社区药剂师在常规执行药物治疗过程 SOAP 时发现了一个关键错误。
一位 78 岁的寡妇去她经常去的社区药房取口腔黏膜炎的处方。药剂师使用 SOAP(主观、客观、评估和计划的缩写)记录方法对病例进行评估,发现了潜在的口服低剂量 MTX 中毒,几天后导致住院。对所需剂量的错误解释源于使用说明书,并导致 MTX 每日(而不是每周)错误摄入。我们在出院后 2 个月对患者进行了家访。她解释说,尽管出现了明显的不良反应,但她继续服用 MTX,是因为她深信自己做的是对的。事件发生后,她对医生的信心没有改变,但现在她将拒绝服用 MTX。
中毒的原因不是偶然发现的,而是社区药剂师通过常规使用药物治疗过程 SOAP 发现的。我们描述了三个可能避免的主要错误,并为医生、药剂师、制造商和患者提供了解决方案,以降低此类风险。我们的案例强调了远程咨询的危险,社区药剂师提供的药物治疗的关键作用,以及继续向开低剂量 MTX 处方的患者提供建议的必要性。患者之前有过类似成功治疗的经验,不应阻止卫生专业人员通过提问和反馈来核实患者的理解。